2001
DOI: 10.1002/jtra.1025
|View full text |Cite
|
Sign up to set email alerts
|

The copper and iron content of brain and liver in the normal and in hepato-lenticular degeneration

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
42
0
2

Year Published

2001
2001
2016
2016

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 32 publications
(47 citation statements)
references
References 9 publications
2
42
0
2
Order By: Relevance
“…While we cannot exclude a reduction in brain tissue water content in conjunction with rising serum and LICs, our postmortem study indicates that to account for the range in R 2 that we observed in the globus pallidus would require a 10% variation in the tissue water content (26). The normal range in the water content for the globus pallidus (74%–76.4%) was reported in one study (27). In our own postmortem study (unpublished data), the water content for control globus pallidus tissue was between 74.2% and 78.3%.…”
Section: Discussionmentioning
confidence: 68%
“…While we cannot exclude a reduction in brain tissue water content in conjunction with rising serum and LICs, our postmortem study indicates that to account for the range in R 2 that we observed in the globus pallidus would require a 10% variation in the tissue water content (26). The normal range in the water content for the globus pallidus (74%–76.4%) was reported in one study (27). In our own postmortem study (unpublished data), the water content for control globus pallidus tissue was between 74.2% and 78.3%.…”
Section: Discussionmentioning
confidence: 68%
“…The discovery of increased copper levels in the brain and liver of Wilson disease (WD) patients led to the introduction of British antilewisite (BAL) and later penicillamineas the first chelating agents for WD. 3 Remarkable progress has been made since, most notably the discovery of ATP7B as the causative WD gene and introduction of other chelating as well as non-chelating agents for its treatment. This review will focus on recent advances in our understanding of WD.…”
Section: Introductionmentioning
confidence: 99%
“…Wilson’s disease is an autosomal recessively inherited disorder that leads to copper accumulation and, consequently, to hepatic damage and neuropsychological symptoms [1], [2]. The causative mutations affect the copper-transporting P-type ATPase ATP7B, which regulates the hepatic copper metabolism, leading to impaired biliary excretion and the toxic accumulation of copper primarily in the brain and liver (reviewed in [3] and [4]).…”
Section: Introductionmentioning
confidence: 99%